Suppr超能文献

[肝脏疾病中的脂质紊乱]

[Lipid disorders in liver diseases].

作者信息

Studeník P

机构信息

Centrum kardiovaskulární a transplantacní chirurgie, Brno.

出版信息

Vnitr Lek. 2000 Sep;46(9):547-8.

Abstract

The liver is the main organ of cholesterol, triglyceride metabolism and lipoprotein synthesis. In diffuse parenchymatous diseases which lead to cirrhosis of the liver a decline of VLDL and HDL particles occurs, as well as a decline of apo-B, apo-E lipoprotein (a). In cholestatic diseases the levels of free cholesterol, phospholipids and sometimes also triglyceride levels rise, in the termonal stage they decline again. A specific marker of cholestasis is the presence of abnormal lipoprotein X, which is formed from non-esterified cholesterol and phsopholipids regurgitating from bile. Primary lipid disorders may then cause liver disease--steatosis. The main risk factors are hypertriglyceridaemias. In the pathogenesis of liver steatosis in particular an increased supply of fatty acids into the liver, is involved, as well as defects in the process of VLDL synthesis and triglyceride release from the liver into the circulation. Hypercholesterolaemia is not a risk factor of steatosis.

摘要

肝脏是胆固醇、甘油三酯代谢及脂蛋白合成的主要器官。在导致肝硬化的弥漫性实质性疾病中,极低密度脂蛋白(VLDL)和高密度脂蛋白(HDL)颗粒会减少,载脂蛋白B、载脂蛋白E、脂蛋白(a)也会减少。在胆汁淤积性疾病中,游离胆固醇、磷脂水平有时还有甘油三酯水平会升高,在终末期又会下降。胆汁淤积的一个特异性标志物是异常脂蛋白X的存在,它由胆汁反流的非酯化胆固醇和磷脂形成。原发性脂质紊乱可能继而导致肝脏疾病——脂肪变性。主要危险因素是高甘油三酯血症。在肝脏脂肪变性的发病机制中,尤其涉及脂肪酸向肝脏供应增加,以及极低密度脂蛋白合成过程和甘油三酯从肝脏释放进入循环的缺陷。高胆固醇血症不是脂肪变性的危险因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验